qtr-four revenue $num-one million versus refinitiv ibes estimate of $102.5 million.
qtrly total births at hospitals where we provided nicu services were up num-one% on a same-unit basis, and nicu days increased num-two%.
qtrly total capital expenditures of $num-one million, down about $4.5 million sequentially.
qtr-three revenue $num-one million versus refinitiv ibes estimate of $1.06 billion.
qtrly u.s. maternal fetal medicine volume was up num-one%.
qtrly hospital volumes increased num-one% on a same unit basis.
compname announces reduction in revolving credit facility capacity to $num-two million from $1.1 billion.
sees fy year-six adjusted ebitda of at least $num-two million.
qtrly net debt was $num-one billion, up num-two% from prior year.
qtr-three transformation and restructuring expense of $num-one million, primarily reflects cost of terminating other third party agreements as part of txt-num transition.
sees fy adjusted ebitda to exceed $num-one million.
sees fy year-six adjusted ebitda to be about num-three% higher than year-five.
sees opportunity for us to open more than num-one pediatric clinics across our footprint within a few years.
qtrly pediatric hospitalist volumes were up num-three% year-over-year.
compname reports qtr-two earnings per share of $num-one.
reaffirms prior view that second half g&a will be lower than $num-one million in first half of year.
